Moraxella (branhamella) catarrhalis polypeptides and corresponding DNA fragments

Details for Australian Patent Application No. 2002325109 (hide)

Owner ID Biomedical Corporation

Inventors Brodeur, Bernard R; Couture, Julie; Hamel, Josee; Rioux, Stephane; Martin, Denis

Agent FB Rice

Pub. Number AU-B-2002325109

PCT Number PCT/CA02/01315

PCT Pub. Number WO2003/018052

Priority 60/314,634 27.08.01 US

Filing date 27 August 2002

Wipo publication date 10 March 2003

Acceptance publication date 10 April 2008

International Classifications

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61P 11/02 (2006.01) Drugs for disorders of the respiratory system

A61P 11/04 (2006.01) Drugs for disorders of the respiratory system

A61P 27/02 (2006.01) Drugs for disorders of the senses

A61P 27/16 (2006.01) Drugs for disorders of the senses

A61P 31/00 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C07K 14/195 (2006.01) Peptides having more than 20 amino acids - from bacteria

C07K 14/21 (2006.01) Peptides having more than 20 amino acids

C07K 19/00 (2006.01) Hybrid peptides

C12N 1/15 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 (2006.01) Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 5/10 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

C12N 15/31 (2006.01) Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

C12P 21/02 (2006.01) Preparation of peptides or proteins - having a known sequence of two or more amino acids, e.g. glutathione

G01N 33/569 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for micro-organisms, e.g. protozoa, bacteria, viruses

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

Event Publications

16 January 2003 Complete Application Filed

  Priority application(s): 60/314,634 27.08.01 US

5 June 2003 Application Open to Public Inspection

  Published as AU-B-2002325109

3 March 2005 Assignment before Grant

  Shire Biochem Inc. The application has been assigned to ID Biomedical Corporation

10 April 2008 Application Accepted

  Published as AU-B-2002325109

7 August 2008 Standard Patent Sealed

6 November 2008 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 01 Oct 2008. Address for service in Australia - FB Rice & Co Level 23 44 Market Street Sydney NSW 2000

24 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002325110-METHOD FOR SYNTHESIZING OXAZINONES

2002325108-SERINE PROTEASE INHIBITOR AND PROCESSES FOR THE PREPARATION THEREOF